Products / Onchology y Oncohematology

Doxetal

Docetaxel 20-80 mg

Docetaxel is indicated for the treatment of operable breast cancer with or without lymph node involvement, lung cancer, prostate cancer, gastric adenocarcinoma, or head and neck cancer.

Therapeutic Action

Antineoplastic

Presentations

1 vial 1 vial with solvent

Doxetal Docetaxel 20-80 mg de Laboratorios Richmond
Download Prospect

Legal Notice

Products which continue to have a valid patent protection at present are manufactured in line with the current laws of the Argentine Republic. Please, take into account that our products will only be shipped to countries where the substance and its use are not protected by patents.

Laboratorios Richmond S.A.C.I.F. Argentina © All rights reserved Terms of use